Grail, Inc. (NASDAQ:GRAL - Get Free Report)'s stock price traded up 3.7% during mid-day trading on Friday . The stock traded as high as $28.59 and last traded at $28.85. 92,793 shares traded hands during trading, a decline of 92% from the average session volume of 1,216,009 shares. The stock had previously closed at $27.81.
Wall Street Analyst Weigh In
Separately, Morgan Stanley lifted their price objective on Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research report on Tuesday, March 18th.
Check Out Our Latest Stock Analysis on Grail
Grail Stock Down 2.9 %
The business has a fifty day moving average of $33.40 and a 200 day moving average of $22.17.
Grail (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. Analysts expect that Grail, Inc. will post -15.15 EPS for the current fiscal year.
Insider Buying and Selling at Grail
In other news, CEO Robert P. Ragusa sold 7,625 shares of the stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.21, for a total transaction of $237,976.25. Following the transaction, the chief executive officer now owns 828,662 shares of the company's stock, valued at approximately $25,862,541.02. This represents a 0.91 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Aaron Freidin sold 1,816 shares of the business's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the completion of the sale, the chief financial officer now owns 335,170 shares of the company's stock, valued at approximately $10,457,304. This trade represents a 0.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 11,550 shares of company stock worth $360,436 over the last three months.
Institutional Trading of Grail
Large investors have recently modified their holdings of the company. FNY Investment Advisers LLC bought a new position in Grail in the 4th quarter worth $26,000. Lindbrook Capital LLC bought a new position in shares of Grail in the fourth quarter worth about $28,000. State of Tennessee Department of Treasury acquired a new position in shares of Grail during the 4th quarter worth about $28,000. Sterling Capital Management LLC bought a new stake in Grail during the 4th quarter valued at approximately $29,000. Finally, Wellington Shields Capital Management LLC acquired a new stake in Grail in the 4th quarter valued at approximately $33,000.
About Grail
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Recommended Stories
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
